Search

Search Constraints

You searched for: Author/Creator Rapoport, Aaron P.

Search Results

1. C-reactive protein: not always a reliable marker of ongoing cytokine release syndrome in CAR-T therapy following IL-6 blockade. Issue 9 (28th July 2020)

2. Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma. Issue 14 (6th December 2019)

3. Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: A single center study. Issue 7 (2nd December 2014)

6. Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphoma. Issue 6 (12th May 2022)

7. Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial. Issue 27 (20th September 2021)

8. Phase 1 study of lenalidomide plus dose‐adjusted EPOCH‐R in patients with aggressive B‐cell lymphomas with deregulated MYC and BCL2. Issue 11 (1st February 2019)

10. Rapid relapse of large B‐cell lymphoma after CD19 directed CAR‐T‐cell therapy due to CD‐19 antigen loss. Issue 10 (13th August 2019)